Pharmaceutical News

RSS

Colorcon announces specific details on its patent positions for enteric coatings

Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.

24 Mar 2011

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Star Scientific, Inc. announced that the company has received notices from the Food and Drug Administration (FDA) regarding its pending ARIVA-BDL™ and STONEWALL-BDL™ modified risk tobacco product applications.

24 Mar 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

WHO report urges countries to step up fight against drug-resistant TB

A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.

24 Mar 2011

Resveratrol can provide resistance before and after hazardous radiation exposure

Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation.

24 Mar 2011

Xirrus deploys high performance Wi-Fi Arrays at EMA

Xirrus, the only Wi-Fi Power Play in the industry, announced today the deployment of Xirrus high performance Wi-Fi Arrays at the European Medicines Agency.

24 Mar 2011

FTC: Granting pharmacists authority over PBMs may increase drug prices, reduce competition

In a letter to Mississippi State Representative Mark Formby this week, the Federal Trade Commission warns that a bill shifting regulatory authority over pharmacy benefit managers from the Mississippi Insurance Commissioner to the Board of Pharmacy "may increase pharmaceutical prices and reduce competition."

24 Mar 2011

House bill proposes immunity for negligent drug manufacturers

Rep. Johnathan Rhyne, Republican Chairman of the NC House Select Committee on Tort Reform, today launched an assault on patients rights, adding provisions to favor insurance companies and drug manufacturers to a controversial Senate bill.

24 Mar 2011

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.

24 Mar 2011

Oral contraceptive use before pregnancy does not pose respiratory problems in children

A new study by researchers at RTI International, the National Institute of Environmental Health Sciences, and the Norwegian Institute of Public Health refutes previous findings that oral contraceptive use before pregnancy is linked to respiratory problems in children.

24 Mar 2011

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat IBD

NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.

24 Mar 2011

New research: Methadone can affect brain and impair intellectual functions

Methadone has been used to treat heroin addicts for nearly 50 years. Yet we have surprisingly incomplete knowledge about possible harmful effects from prolonged use. New research from the Norwegian Institute of Public Health shows that methadone affects the brain and impairs the attention of experimental animals.

24 Mar 2011

USPTO grants patent to ULURU's Altrazeal product

ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.

24 Mar 2011

Ansell announces substantial price increase for NRL medical gloves

Following a continued increase of raw materials costs, Ansell Medical Solutions Europe, the regional branch of the world leader in hand protective solutions for healthcare professionals, has announced substantial price increases for its entire range of NRL medical gloves.

23 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

23 Mar 2011

SGEN, Abbott enter collaboration agreement for ADC products

Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.

23 Mar 2011

POZEN files motion for Treximet patent litigation against Par

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. from launching a generic version of Treximet.

23 Mar 2011

Pharmaceutical News

Colorcon announces specific details on its patent positions for enteric coatings

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

WHO report urges countries to step up fight against drug-resistant TB

Resveratrol can provide resistance before and after hazardous radiation exposure

Xirrus deploys high performance Wi-Fi Arrays at EMA

FTC: Granting pharmacists authority over PBMs may increase drug prices, reduce competition

House bill proposes immunity for negligent drug manufacturers

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Oral contraceptive use before pregnancy does not pose respiratory problems in children

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

NephRx receives new U.S. patent for NX002 to treat IBD

New research: Methadone can affect brain and impair intellectual functions

USPTO grants patent to ULURU's Altrazeal product

Ansell announces substantial price increase for NRL medical gloves

Cilag, POZEN enter license agreement to develop and commercialize MT 400

NephRx receives new U.S. patent for NX002 to treat oral mucositis

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

SGEN, Abbott enter collaboration agreement for ADC products

POZEN files motion for Treximet patent litigation against Par

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News